| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Former 10% Owner
6 companies
Boxer Capital, LLC is a 10% Owner at Tango Therapeutics, Inc. with holdings across 6 companies. Recent SEC Form 4 filings include 13 buys and 13 sells.
Estimated insider holdings value: $222.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 16, 2023 | TNGX Tango Therapeutics, Inc. | - | Buy | 1,250,000 | $6.98 | $8,722,500.00 | +8.5% | +62.0% | +6.0% | |
| Oct 9, 2023 | TNGX Tango Therapeutics, Inc. | - | Sell | 225,000 | $9.96 | $2,240,250.00 | -2.9% | -4.1% | -30.2% | |
| Aug 11, 2023 | TNGX Tango Therapeutics, Inc. | - | Buy | 475,000 | $5.15 | $2,446,250.00 | +176.9% | +11.9% | +13.2% | |
| Oct 13, 2022 | TNGX Tango Therapeutics, Inc. | 10% Owner | Buy | 237,000 | $4.41 | $1,044,573.30 | +3.2% | +66.2% | +62.6% | |
| Oct 6, 2022 | TNGX Tango Therapeutics, Inc. | 10% Owner | Buy | 182,000 | $3.92 | $714,096.47 | +0.7% | +87.8% | +176.9% | |
| Dec 17, 2021 | TYRA Tyra Biosciences, Inc. | 10% Owner | Buy | 125,000 | $13.12 | $1,640,312.50 | +2.0% | -3.6% | -44.0% | |
| Sep 17, 2021 | TYRA Tyra Biosciences, Inc. | 10% Owner | Buy | 625,000 | $16.00 | $10,000,000.00 | +11.0% | -31.0% | -61.1% | |
| Sep 25, 2020 | PMVP Pmv Pharmaceuticals, Inc. | Former 10% Owner | Buy | 950,000 | $18.00 | $17,100,000.00 | New | - | - | |
| Mar 28, 2019 | SLDB Solid Biosciences Inc. | 10% Owner | Sell | 450,000 | $9.88 | $4,447,800.00 | -4.1% | - | - | |
| Nov 5, 2018 | ESPR Esperion Therapeutics, Inc. | 10% Owner | Sell | 100,000 | $56.38 | $5,638,342.60 | -1.1% | - | - |